Blood Cell Response to Exercise

Sponsor
USDA Grand Forks Human Nutrition Research Center (U.S. Fed)
Overall Status
Withdrawn
CT.gov ID
NCT01872273
Collaborator
(none)
0
40

Study Details

Study Description

Brief Summary

Moderate exercise is recommended to improve cardiovascular health in obese and overweight people particularly with metabolic syndrome (MetS) that have hypertension, elevated fasting blood sugar, and elevated blood lipids. This study is being done to determine how platelets respond when a person performs an initial period of moderate exercise.

Condition or Disease Intervention/Treatment Phase
  • Other: Moderate Physical Exercise

Study Design

Study Type:
Observational
Actual Enrollment :
0 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Blood Cell Response to Exercise
Study Start Date :
Feb 1, 2013
Actual Primary Completion Date :
Jun 1, 2016
Actual Study Completion Date :
Jun 1, 2016

Outcome Measures

Primary Outcome Measures

  1. Platelet Reactivity [Baseline, post-intervention (24 hours), & time points during the exercise phase: prior to exercise (-25 min, -10 min, - 1 min), 10 minutes into the routine, at completion (25 minutes), and 20 & 60 minutes following completion]

    We hypothesize that moderate physical exercise will increase platelet reactivity in sedentary individuals with metabolic syndrome. Platelet reactivity will be measured by flow cytometry using anti-CD61 antibodies as a marker for platelets and anti-CD62 (P-selectin) as a marker of platelet activation. This will be measured at baseline, post-intervention and time points post-baseline in each subject.

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 30-60 years old

  • BMI >/=26 and <40 kg/m2

  • not planning to or currently attempting to gain or lose weight

  • low reported omega-3 fatty acid intake per Omega-3 Checklist

  • Metabolic Syndrome as define 3/5 of the following:Waist circumference: men > 102 cm women > 88 cm, triglycerides > 150 mg/dL, HDL cholesterol: men < 40 mg/dL women < 50 mg/dL,Blood pressure >130/>85 mmHg,Fasting glucose > 100 mg/dL (Hypertensive subjects are eligible if taking thiazide diuretics NOT ACE inhibitors beta blockers)

Exclusion Criteria:
  • smoke or use tobacco or nicotine in any form (including pills and patches)

  • take any medication that makes you unable to exercise

  • have established cardiovascular, pulmonary, and/or metabolic disease such as diabetes

  • have uncontrolled hypertension

  • have alcohol, anabolic steroid, or other substance abuse issues

  • consume more than 3 alcoholic drinks/week

  • have joint or muscle injuries that affects your ability to exercise

  • have cancer (other than skin cancer or carcinoma in situ of the cervix

  • pregnant or lactating

  • currently exercise regularly

  • taking non-steroidal anti-inflammatory medications (aspirin, Aleve, Advil, ibuprofen, naproxen

  • take lipid modifying medications such as statins (Lipitor, Zocor)

  • take medications for blood glucose such as insulin or metformin

  • take medications that affect platelet functions (Plavix)

  • taking omega-3 supplements (fish or flax oil)

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • USDA Grand Forks Human Nutrition Research Center

Investigators

  • Principal Investigator: Matthew Picklo, PhD, USDA Grand Forks Human Nutrition Research Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
USDA Grand Forks Human Nutrition Research Center
ClinicalTrials.gov Identifier:
NCT01872273
Other Study ID Numbers:
  • GFHNRC026
First Posted:
Jun 7, 2013
Last Update Posted:
Feb 2, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by USDA Grand Forks Human Nutrition Research Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 2, 2022